TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2017 DA - 2017// TI - Cancer statistics, 2017 JO - CA Cancer J Clin VL - 67 UR - https://doi.org/10.3322/caac.21387 DO - 10.3322/caac.21387 ID - Siegel2017 ER - TY - JOUR AU - Kitahara, C. M. AU - Sosa, J. A. PY - 2016 DA - 2016// TI - The changing incidence of thyroid cancer JO - Nat Rev Endocrinol VL - 12 UR - https://doi.org/10.1038/nrendo.2016.110 DO - 10.1038/nrendo.2016.110 ID - Kitahara2016 ER - TY - JOUR AU - Gara, S. K. AU - Jia, L. AU - Merino, M. J. PY - 2015 DA - 2015// TI - Germline HABP2 mutation causing familial nonmedullary thyroid cancer JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1502449 DO - 10.1056/NEJMoa1502449 ID - Gara2015 ER - TY - JOUR AU - Schlumberger, M. AU - Elisei, R. AU - Müller, S. PY - 2017 DA - 2017// TI - Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx479 DO - 10.1093/annonc/mdx479 ID - Schlumberger2017 ER - TY - JOUR AU - Molinaro, E. AU - Romei, C. AU - Biagini, A. PY - 2017 DA - 2017// TI - Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies JO - Nat Rev Endocrinol VL - 13 UR - https://doi.org/10.1038/nrendo.2017.76 DO - 10.1038/nrendo.2017.76 ID - Molinaro2017 ER - TY - JOUR AU - Cabanillas, M. E. AU - McFadden, D. G. AU - Durante, C. PY - 2016 DA - 2016// TI - Thyroid cancer JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)30172-6 DO - 10.1016/S0140-6736(16)30172-6 ID - Cabanillas2016 ER - TY - JOUR AU - Liu, D. AU - Hou, P. AU - Liu, Z. PY - 2009 DA - 2009// TI - Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-09-1077 DO - 10.1158/0008-5472.CAN-09-1077 ID - Liu2009 ER - TY - JOUR AU - Capdevila, J. AU - Mayor, R. AU - Mancuso, F. M. PY - 2018 DA - 2018// TI - Early evolutionary divergence between papillary and anaplastic thyroid cancers JO - Ann Oncol VL - 29 UR - https://doi.org/10.1093/annonc/mdy123 DO - 10.1093/annonc/mdy123 ID - Capdevila2018 ER - TY - JOUR AU - Brose, M. S. AU - Nutting, C. M. AU - Jarzab, B. PY - 2014 DA - 2014// TI - Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial JO - Lancet VL - 384 UR - https://doi.org/10.1016/S0140-6736(14)60421-9 DO - 10.1016/S0140-6736(14)60421-9 ID - Brose2014 ER - TY - JOUR AU - Broecker-Preuss, M. AU - Müller, S. AU - Britten, M. PY - 2015 DA - 2015// TI - Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1186-0 DO - 10.1186/s12885-015-1186-0 ID - Broecker-Preuss2015 ER - TY - JOUR AU - Wang, J. AU - Man, G. C. W. AU - Chan, T. H. PY - 2018 DA - 2018// TI - A prodrug of green tea polyphenol (–)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer JO - Cancer Lett VL - 412 UR - https://doi.org/10.1016/j.canlet.2017.09.054 DO - 10.1016/j.canlet.2017.09.054 ID - Wang2018 ER - TY - JOUR AU - Torello, C. O. AU - Shiraishi, R. N. AU - Della Via, F. I. PY - 2018 DA - 2018// TI - Reactive oxygen species production triggers green tea-induced anti-leukaemic effects on acute promyelocytic leukaemia model JO - Cancer Lett VL - 414 UR - https://doi.org/10.1016/j.canlet.2017.11.006 DO - 10.1016/j.canlet.2017.11.006 ID - Torello2018 ER - TY - JOUR AU - Ugai, T. AU - Matsuo, K. AU - Sawada, N. PY - 2018 DA - 2018// TI - Coffee and green tea consumption and subsequent risk of acute myeloid leukemia and myelodysplastic syndromes in Japan JO - Int J Cancer VL - 142 UR - https://doi.org/10.1002/ijc.31135 DO - 10.1002/ijc.31135 ID - Ugai2018 ER - TY - JOUR AU - Ko, H. AU - So, Y. AU - Jeon, H. PY - 2013 DA - 2013// TI - TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells JO - Cancer Lett VL - 335 UR - https://doi.org/10.1016/j.canlet.2013.02.018 DO - 10.1016/j.canlet.2013.02.018 ID - Ko2013 ER - TY - JOUR AU - Gan, R. Y. AU - Li, H. B. AU - Sui, Z. Q. PY - 2018 DA - 2018// TI - Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): an updated review JO - Crit Rev Food Sci Nutr VL - 58 UR - https://doi.org/10.1080/10408398.2016.1231168 DO - 10.1080/10408398.2016.1231168 ID - Gan2018 ER - TY - JOUR AU - Afzal, M. AU - Safer, A. M. AU - Menon, M. PY - 2015 DA - 2015// TI - Green tea polyphenols and their potential role in health and disease JO - Inflammopharmacology VL - 23 UR - https://doi.org/10.1007/s10787-015-0236-1 DO - 10.1007/s10787-015-0236-1 ID - Afzal2015 ER - TY - JOUR AU - Oliveira, M. R. AU - Nabavi, S. F. AU - Daglia, M. PY - 2016 DA - 2016// TI - Epigallocatechin gallate and mitochondria—a story of life and death JO - Pharmacol Res VL - 104 UR - https://doi.org/10.1016/j.phrs.2015.12.027 DO - 10.1016/j.phrs.2015.12.027 ID - Oliveira2016 ER - TY - JOUR AU - Modernelli, A. AU - Naponelli, V. AU - Giovanna Troglio, M. PY - 2015 DA - 2015// TI - EGCG antagonizes bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep15270 DO - 10.1038/srep15270 ID - Modernelli2015 ER - TY - JOUR AU - Butt, M. S. AU - Ahmad, R. S. AU - Sultan, M. T. PY - 2015 DA - 2015// TI - Green tea and anticancer perspectives: updates from last decade JO - Crit Rev Food Sci Nutr VL - 55 UR - https://doi.org/10.1080/10408398.2012.680205 DO - 10.1080/10408398.2012.680205 ID - Butt2015 ER - TY - JOUR AU - Wang, H. AU - Bian, S. AU - Yang, C. S. PY - 2011 DA - 2011// TI - Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1α JO - Carcinogenesis VL - 32 UR - https://doi.org/10.1093/carcin/bgr218 DO - 10.1093/carcin/bgr218 ID - Wang2011 ER - TY - JOUR AU - Singh, A. K. AU - Sharma, N. AU - Ghosh, M. PY - 2017 DA - 2017// TI - Emerging importance of dietary phytochemicals in fight against cancer: role in targeting cancer stem cells JO - Crit Rev Food Sci Nutr VL - 57 UR - https://doi.org/10.1080/10408398.2015.1129310 DO - 10.1080/10408398.2015.1129310 ID - Singh2017 ER - TY - JOUR AU - Shammas, M. A. AU - Neri, P. AU - Koley, H. PY - 2006 DA - 2006// TI - Specific killing of multiple myeloma cells by (–)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications JO - Blood VL - 108 UR - https://doi.org/10.1182/blood-2006-05-022814 DO - 10.1182/blood-2006-05-022814 ID - Shammas2006 ER - TY - JOUR AU - Chow, H. H. AU - Cai, Y. AU - Hakim, I. A. PY - 2003 DA - 2003// TI - Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals JO - Clin Cancer Res VL - 9 ID - Chow2003 ER - TY - JOUR AU - Wu, D. AU - Luo, N. AU - Wang, L. PY - 2017 DA - 2017// TI - Hydrogen sulfide ameliorates chronic renal failure in rats by inhibiting apoptosis and inflammation through ROS/MAPK and NF-κB signaling pathways JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-00557-2 DO - 10.1038/s41598-017-00557-2 ID - Wu2017 ER - TY - JOUR AU - Wu, D. AU - Li, M. AU - Tian, W. PY - 2017 DA - 2017// TI - Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-05457-z DO - 10.1038/s41598-017-05457-z ID - Wu2017 ER - TY - JOUR AU - Wu, D. D. AU - Gao, Y. R. AU - Li, T. PY - 2018 DA - 2018// TI - PEST-containing nuclear protein mediates the proliferation, migration, and invasion of human neuroblastoma cells through MAPK and PI3K/AKT/mTOR signaling pathways JO - BMC Cancer VL - 18 UR - https://doi.org/10.1186/s12885-018-4391-9 DO - 10.1186/s12885-018-4391-9 ID - Wu2018 ER - TY - JOUR AU - Heilmann, A. M. AU - Perera, R. M. AU - Ecker, V. PY - 2014 DA - 2014// TI - CDK4/6 and IGF1 receptor inhibitors synergize to suppress the growth of p16INK4A-deficient pancreatic cancers JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-13-2923 DO - 10.1158/0008-5472.CAN-13-2923 ID - Heilmann2014 ER - TY - JOUR AU - Determann, O. AU - Hoster, E. AU - Ott, G. PY - 2008 DA - 2008// TI - Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL network and the German low grade lymphoma study group JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-10-117010 DO - 10.1182/blood-2007-10-117010 ID - Determann2008 ER - TY - JOUR AU - Koukourakis, M. I. AU - Giatromanolaki, A. AU - Thorpe, P. E. PY - 2000 DA - 2000// TI - Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer JO - Cancer Res VL - 60 ID - Koukourakis2000 ER - TY - JOUR AU - Otto, T. AU - Sicinski, P. PY - 2017 DA - 2017// TI - Cell cycle proteins as promising targets in cancer therapy JO - Nat Rev Cancer VL - 17 UR - https://doi.org/10.1038/nrc.2016.138 DO - 10.1038/nrc.2016.138 ID - Otto2017 ER - TY - JOUR AU - Wang, S. S. AU - Lv, Y. AU - Xu, X. C. PY - 2019 DA - 2019// TI - Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling JO - Cancer Lett VL - 443 UR - https://doi.org/10.1016/j.canlet.2018.11.028 DO - 10.1016/j.canlet.2018.11.028 ID - Wang2019 ER - TY - JOUR AU - Pitchakarn, P. AU - Suzuki, S. AU - Ogawa, K. PY - 2011 DA - 2011// TI - Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf JO - Cancer Lett VL - 306 UR - https://doi.org/10.1016/j.canlet.2011.02.041 DO - 10.1016/j.canlet.2011.02.041 ID - Pitchakarn2011 ER - TY - JOUR AU - Chen, M. AU - Wang, X. AU - Zha, D. PY - 2016 DA - 2016// TI - Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep35468 DO - 10.1038/srep35468 ID - Chen2016 ER - TY - JOUR AU - Kitagawa, M. AU - Liao, P. J. AU - Lee, K. H. PY - 2017 DA - 2017// TI - Dual blockade of the lipid kinase PIP4Ks and mitotic pathways leads to cancer-selective lethality JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/s41467-017-02287-5 DO - 10.1038/s41467-017-02287-5 ID - Kitagawa2017 ER - TY - JOUR AU - Knight, T. AU - Irving, J. A. PY - 2014 DA - 2014// TI - Ras/Raf/MEK/ERK pathway activation in childhood acute lymphoblastic leukemia and its therapeutic targeting JO - Front Oncol VL - 4 UR - https://doi.org/10.3389/fonc.2014.00160 DO - 10.3389/fonc.2014.00160 ID - Knight2014 ER - TY - JOUR AU - Poulikakos, P. I. AU - Rosen, N. PY - 2011 DA - 2011// TI - Mutant BRAF melanomas-dependence and resistance JO - Cancer Cell VL - 19 UR - https://doi.org/10.1016/j.ccr.2011.01.008 DO - 10.1016/j.ccr.2011.01.008 ID - Poulikakos2011 ER - TY - JOUR AU - Peng, J. AU - Gassama-Diagne, A. PY - 2017 DA - 2017// TI - Apicobasal polarity and Ras/Raf/MEK/ERK signalling in cancer JO - Gut VL - 66 UR - https://doi.org/10.1136/gutjnl-2016-312986 DO - 10.1136/gutjnl-2016-312986 ID - Peng2017 ER - TY - JOUR AU - Wan, L. AU - Chen, M. AU - Cao, J. PY - 2017 DA - 2017// TI - The APC/C E3 ligase complex activator FZR1 restricts BRAF oncogenic function JO - Cancer Discov VL - 7 UR - https://doi.org/10.1158/2159-8290.CD-16-0647 DO - 10.1158/2159-8290.CD-16-0647 ID - Wan2017 ER - TY - JOUR AU - Troiani, T. AU - Napolitano, S. AU - Vitagliano, D. PY - 2014 DA - 2014// TI - Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2181 DO - 10.1158/1078-0432.CCR-13-2181 ID - Troiani2014 ER - TY - JOUR AU - Bentzien, F. AU - Zuzow, M. AU - Heald, N. PY - 2013 DA - 2013// TI - In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer JO - Thyroid VL - 23 UR - https://doi.org/10.1089/thy.2013.0137 DO - 10.1089/thy.2013.0137 ID - Bentzien2013 ER - TY - JOUR AU - Hong, S. AU - Yu, S. AU - Li, J. PY - 2016 DA - 2016// TI - MiR-20b displays tumor-suppressor functions in papillary thyroid carcinoma by regulating the MAPK/ERK signaling pathway JO - Thyroid VL - 26 UR - https://doi.org/10.1089/thy.2015.0578 DO - 10.1089/thy.2015.0578 ID - Hong2016 ER - TY - JOUR AU - So, Y. AU - Lee, Y. J. AU - Lee, W. W. PY - 2013 DA - 2013// TI - Determination of the optimal time for radioiodine therapy in anaplastic thyroid carcinoma using the adenovirus-mediated transfer of sodium iodide symporter gene JO - Oncol Rep VL - 29 UR - https://doi.org/10.3892/or.2013.2277 DO - 10.3892/or.2013.2277 ID - So2013 ER - TY - JOUR AU - Amicis, F. AU - Perri, A. AU - Vizza, D. PY - 2013 DA - 2013// TI - Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines JO - J Cell Physiol VL - 228 UR - https://doi.org/10.1002/jcp.24372 DO - 10.1002/jcp.24372 ID - Amicis2013 ER - TY - JOUR AU - Wu, D. AU - Si, W. AU - Wang, M. PY - 2015 DA - 2015// TI - Hydrogen sulfide in cancer: friend or foe? JO - Nitric Oxide VL - 50 UR - https://doi.org/10.1016/j.niox.2015.08.004 DO - 10.1016/j.niox.2015.08.004 ID - Wu2015 ER - TY - JOUR AU - Palumbo, T. AU - Poultsides, G. A. AU - Kouraklis, G. PY - 2016 DA - 2016// TI - A functional microRNA library screen reveals miR-410 as a novel anti-apoptotic regulator of cholangiocarcinoma JO - BMC Cancer VL - 16 UR - https://doi.org/10.1186/s12885-016-2384-0 DO - 10.1186/s12885-016-2384-0 ID - Palumbo2016 ER - TY - JOUR AU - Wu, D. AU - Gao, Y. AU - Qi, Y. PY - 2014 DA - 2014// TI - Peptide-based cancer therapy: opportunity and challenge JO - Cancer Lett VL - 351 UR - https://doi.org/10.1016/j.canlet.2014.05.002 DO - 10.1016/j.canlet.2014.05.002 ID - Wu2014 ER - TY - JOUR AU - Ke, F. F. S. AU - Vanyai, H. K. AU - Cowan, A. D. PY - 2018 DA - 2018// TI - Embryogenesis and adult life in the absence of intrinsic apoptosis effectors BAX, BAK, and BOK JO - Cell VL - 173 UR - https://doi.org/10.1016/j.cell.2018.04.036 DO - 10.1016/j.cell.2018.04.036 ID - Ke2018 ER - TY - JOUR AU - Manohar, M. AU - Fatima, I. AU - Saxena, R. PY - 2013 DA - 2013// TI - (–)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation JO - J Nutr Biochem VL - 24 UR - https://doi.org/10.1016/j.jnutbio.2012.06.013 DO - 10.1016/j.jnutbio.2012.06.013 ID - Manohar2013 ER - TY - JOUR AU - Hu, Q. AU - Chang, X. AU - Yan, R. PY - 2015 DA - 2015// TI - (–)-Epigallocatechin-3-gallate induces cancer cell apoptosis via acetylation of amyloid precursor protein JO - Med Oncol VL - 32 UR - https://doi.org/10.1007/s12032-014-0390-0 DO - 10.1007/s12032-014-0390-0 ID - Hu2015 ER - TY - JOUR AU - Tang, G. Q. AU - Yan, T. Q. AU - Guo, W. PY - 2010 DA - 2010// TI - (–)-Epigallocatechin-3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells JO - J Cancer Res Clin Oncol VL - 136 UR - https://doi.org/10.1007/s00432-010-0765-3 DO - 10.1007/s00432-010-0765-3 ID - Tang2010 ER - TY - JOUR AU - Wang, J. AU - Xie, Y. AU - Feng, Y. PY - 2015 DA - 2015// TI - (–)-Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase-dependent pathway and Bcl-2 family protein modulation JO - Int J Oncol VL - 46 UR - https://doi.org/10.3892/ijo.2015.2869 DO - 10.3892/ijo.2015.2869 ID - Wang2015 ER - TY - JOUR AU - Alessio, N. AU - Gaudio, S. AU - Capasso, S. PY - 2015 DA - 2015// TI - Low dose radiation induced senescence of human mesenchymal stromal cells and impaired the autophagy process JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.2692 DO - 10.18632/oncotarget.2692 ID - Alessio2015 ER - TY - JOUR AU - Mandal, R. AU - Becker, S. AU - Strebhardt, K. PY - 2016 DA - 2016// TI - Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy JO - Oncogene VL - 35 UR - https://doi.org/10.1038/onc.2015.329 DO - 10.1038/onc.2015.329 ID - Mandal2016 ER - TY - JOUR AU - Nichols, R. J. AU - Haderk, F. AU - Stahlhut, C. PY - 2018 DA - 2018// TI - RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers JO - Nat Cell Biol VL - 20 UR - https://doi.org/10.1038/s41556-018-0169-1 DO - 10.1038/s41556-018-0169-1 ID - Nichols2018 ER - TY - JOUR AU - Gourlaouen, M. AU - Welti, J. C. AU - Vasudev, N. S. PY - 2013 DA - 2013// TI - Essential role for endocytosis in the growth factor-stimulated activation of ERK1/2 in endothelial cells JO - J Biol Chem VL - 288 UR - https://doi.org/10.1074/jbc.M112.446401 DO - 10.1074/jbc.M112.446401 ID - Gourlaouen2013 ER - TY - JOUR AU - Roskoski, R. PY - 2018 DA - 2018// TI - Targeting oncogenic Raf protein-serine/threonine kinases in human cancers JO - Pharmacol Res VL - 135 UR - https://doi.org/10.1016/j.phrs.2018.08.013 DO - 10.1016/j.phrs.2018.08.013 ID - Roskoski2018 ER - TY - JOUR AU - Xing, M. PY - 2013 DA - 2013// TI - Molecular pathogenesis and mechanisms of thyroid cancer JO - Nat Rev Cancer VL - 13 UR - https://doi.org/10.1038/nrc3431 DO - 10.1038/nrc3431 ID - Xing2013 ER - TY - JOUR AU - Koustas, E. AU - Karamouzis, M. V. AU - Mihailidou, C. PY - 2017 DA - 2017// TI - Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer JO - Cancer Lett VL - 396 UR - https://doi.org/10.1016/j.canlet.2017.03.023 DO - 10.1016/j.canlet.2017.03.023 ID - Koustas2017 ER - TY - JOUR AU - Li, K. AU - Guo, Q. AU - Yang, J. PY - 2017 DA - 2017// TI - FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway JO - Oncotarget VL - 8 ID - Li2017 ER - TY - JOUR AU - Ouyang, L. AU - Chen, Y. AU - Wang, X. Y. PY - 2014 DA - 2014// TI - Polygonatum odoratum lectin induces apoptosis and autophagy via targeting EGFR-mediated Ras-Raf-MEK-ERK pathway in human MCF-7 breast cancer cells JO - Phytomedicine VL - 21 UR - https://doi.org/10.1016/j.phymed.2014.08.002 DO - 10.1016/j.phymed.2014.08.002 ID - Ouyang2014 ER - TY - JOUR AU - Angelova, M. AU - Mlecnik, B. AU - Vasaturo, A. PY - 2018 DA - 2018// TI - Evolution of metastases in space and time under immune selection JO - Cell VL - 175 UR - https://doi.org/10.1016/j.cell.2018.09.018 DO - 10.1016/j.cell.2018.09.018 ID - Angelova2018 ER - TY - JOUR AU - Liu, Y. AU - Jang, S. AU - Xie, L. PY - 2014 DA - 2014// TI - Host deficiency in caveolin-2 inhibits lung carcinoma tumor growth by impairing tumor angiogenesis JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-14-1408 DO - 10.1158/0008-5472.CAN-14-1408 ID - Liu2014 ER -